Crystal structure of NLRC4 reveals its autoinhibition mechanism

Zehan Hu1, Chuangye Yan, Peiyuan Liu

  • 1School of Life Sciences, Tsinghua University, and Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.

Science (New York, N.Y.)
|June 15, 2013
PubMed

Insights

Nucleotide-binding and oligomerization domain-like receptor (NLR) proteins, like NLRC4, use a novel autoinhibition mechanism. This involves interactions between domains, keeping NLRC4 inactive until specific signals trigger its activation.

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Biology

Background:

  • Nucleotide-binding and oligomerization domain-like receptor (NLR) proteins form inflammasomes upon activation.
  • The precise autoinhibition mechanisms of NLR proteins are not fully understood.

Purpose of the Study:

  • To elucidate the autoinhibition mechanism of mouse NLRC4.
  • To determine the structural basis for NLRC4's inactive state.

Main Methods:

  • X-ray crystallography to obtain the closed-form structure of mouse NLRC4.
  • Biochemical analysis to investigate domain interactions and their role in autoinhibition.

Main Results:

  • The crystal structure revealed NLRC4 in a closed conformation.
  • Adenosine diphosphate (ADP)-mediated interactions between the nucleotide-binding domain (NBD) and winged-helix domain (WHD), and between NBD and helical domain 2 (HD2)/leucine-rich repeat (LRR) domain, stabilize the autoinhibited state.
  • Disrupting these interactions led to constitutive NLRC4 activation.

Conclusions:

  • NLRC4 is autoinhibited through a cooperative mechanism organized by the NBD.
  • Specific inter-domain interactions, stabilized by ADP, are crucial for maintaining NLRC4 in its inactive, monomeric state.
  • Understanding this mechanism provides insights into inflammasome activation pathways.